Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT06252051
Eligibility Criteria:
Inclusion Criteria:
Group 1 (T2DM)
* Individuals with Type 2 Diabetes Mellitus (T2DM)
* Age range: 40-59 years
Group 2 (T2DM-CKD):
* Individuals with Type 2 Diabetes Mellitus (T2DM)
* Age range: 40-59 years
* eGFR (ml/min/1.73 m2) \>15
* eGFR (ml/min/1.73 m2) \<89
* Proteinuria
Group 3 (Healthy Person) :
* Individuals without Type 2 Diabetes Mellitus (T2DM)
* Age range: 40-59 years
Exclusion Criteria:
* Incomplete medical records
* CKD Stage 5
* Currently pregnant
* Currently on long-term steroid use
* Received influenza vaccine in the last year
* Diagnosed with malignancy
* Autoimmune disease
* History of allergy to chicken eggs or vaccine constituents
* High fever, seizures, or acute infection
* History of COVID infection based on PCR testing with the last PCR result negative \<14 days
* History of COVID-19 vaccination \<14 days from the last vaccine administration
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
49 Years
Study:
NCT06252051
Study Brief:
Protocol Section:
NCT06252051